FEATURED · MARKETS China Life’s revenue surges as top insurer ramps up investment in AI, chips and biotech
August 28, 2026 1 min read
MARKETS

China Life’s revenue surges as top insurer ramps up investment in AI, chips and biotech

Source: SCMP — Business & Markets

PUBLISHED
August 28, 2026
CATEGORY
SC
SCMP — Business & Markets
eChina Team
1

Company pledges long-term support for tech-innovation after revenue jumps 81 per cent and net profit soars 228 per cent The Shanghai- and Hong Kong-listed insurer recorded revenue of 434.3 billion yuan (US$64.6 billion), up 81.5 per cent year on year, according to interim results released on Thursday. Net profit surged more than 228 per cent to 134.5 billion yuan. The company, the world’s largest life insurer by market value, attributed profit growth to business development with risk control, progress in product and business diversification, refined asset allocation and robust investment returns. “Investment in areas related to new quality productive forces represents a key growth driver best positioned to deliver differentiated returns, and there lies broad potential for future investment and layout,” vice-president Liu Hui said at a press briefing in Beijing on Friday.

Comments

İlk yorumu siz yazın!

Yorumunuzu yazın